{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:18:37Z","timestamp":1786119517057,"version":"build-2736575974"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1097\/mjt.0b013e318195e460","type":"journal-article","created":{"date-parts":[[2009,1,13]],"date-time":"2009-01-13T03:13:54Z","timestamp":1231816434000},"page":"86-92","source":"Crossref","is-referenced-by-count":39,"title":["The Clinical Pharmacology of Ethacrynic Acid"],"prefix":"10.1097","volume":"16","author":[{"given":"Janos","family":"Molnar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C","family":"Somberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-15-20210202","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1136\/bmj.2.5464.732","article-title":"Ethacrynic acid: two years experience with a new diuretic.","volume":"2","author":"Ledingham","year":"1965","journal-title":"Br Med J"},{"key":"R3-15-20210202","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1056\/NEJM196509092731103","article-title":"Ethacrynic acid in acute pulmonary edema.","volume":"273","author":"Fine","year":"1965","journal-title":"N Engl J Med"},{"key":"R4-15-20210202","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM196807182790301","article-title":"Controlled study comparing ethacrynic acid to mercaptomerin in the treatment of acute pulmonary edema.","volume":"279","author":"Lesch","year":"1968","journal-title":"N Engl J Med"},{"key":"R5-15-20210202","first-page":"435","article-title":"The treatment of acute pulmonary edema with furosemide.","volume":"8","author":"Weinstein","year":"1966","journal-title":"Curr Ther Res Clin Exp"},{"key":"R6-15-20210202","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0167-5273(01)00600-3","article-title":"Current evidence supporting the role of diuretics in heart failure: a meta analysis of randomised controlled trials.","volume":"82","author":"Faris","year":"2002","journal-title":"Int J Cardiol"},{"key":"R7-15-20210202","first-page":"504","article-title":"Molecular mechanisms.","volume":"19","author":"Hebert","year":"1999","journal-title":"Semin Nephrol"},{"key":"R8-15-20210202","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1172\/JCI104905","article-title":"Effects of ethacrynic acid (a new saluretic agent) on renal diluting and concentrating mechanisms: evidence for site of action in the loop of Henle.","volume":"43","author":"Goldberg","year":"1964","journal-title":"J Clin Invest"},{"key":"R9-15-20210202","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/0735-1097(96)00161-1","article-title":"Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion.","volume":"28","author":"Dormans","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"R10-15-20210202","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S0008-6363(96)00134-4","article-title":"Vascular effects of loop diuretics.","volume":"32","author":"Dormans","year":"1996","journal-title":"Cardiovasc Res"},{"key":"R11-15-20210202","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1161\/01.CIR.53.2.364","article-title":"The acute hemodynamic effects of ethacrynic acid and furosemide in patients with chronic postcapillary pulmonary hypertension.","volume":"53","author":"Austin","year":"1976","journal-title":"Circulation"},{"key":"R14-15-20210202","doi-asserted-by":"crossref","first-page":"24556","DOI":"10.1074\/jbc.272.39.24556","article-title":"Ion and bumetanide binding by the Na-K-Cl cotransporter. Importance of transmembrane domains.","volume":"272","author":"Isenring","year":"1997","journal-title":"J Biol Chem"},{"issue":"Suppl 3","key":"R15-15-20210202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003495-199100413-00003","article-title":"How do loop diuretics act?","volume":"41","author":"Wittner","year":"1991","journal-title":"Drugs"},{"key":"R16-15-20210202","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0002-9149(71)90438-3","article-title":"Ethacrynic acid and furosemide. Diuretic and hemodynamic effects and clinical uses.","volume":"27","author":"Kim","year":"1971","journal-title":"Am J Cardiol"},{"key":"R17-15-20210202","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0002-9149(65)90013-5","article-title":"Pharmacodynamic effects of a new diuretic drug, ethacrynic acid.","volume":"16","author":"Brest","year":"1965","journal-title":"Am J Cardiol"},{"key":"R18-15-20210202","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/0002-9149(68)90232-4","article-title":"Efficacy of ethacrynic acid in patients with refractory congestive heart failure resistant to meralluride.","volume":"22","author":"Siegel","year":"1968","journal-title":"Am J Cardiol"},{"key":"R19-15-20210202","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1161\/01.CIR.31.1.5","article-title":"Ethacrynic acid: effectiveness and mode of diuretic action in man.","volume":"31","author":"Cannon","year":"1965","journal-title":"Circulation"},{"key":"R20-15-20210202","doi-asserted-by":"crossref","first-page":"531","DOI":"10.5694\/j.1326-5377.1965.tb19004.x","article-title":"Treatment of resistant oedema with new diuretics: ethacrynic acid and frusemide.","volume":"2","author":"Barnett","year":"1965","journal-title":"Med J Aust"},{"key":"R21-15-20210202","doi-asserted-by":"crossref","first-page":"533","DOI":"10.5694\/j.1326-5377.1966.tb72574.x","article-title":"Ethacrynic acid in the treatment of patients resistant to thiazides.","volume":"1","author":"Doyle","year":"1966","journal-title":"Med J Aust"},{"key":"R22-15-20210202","doi-asserted-by":"crossref","first-page":"15","DOI":"10.7326\/0003-4819-62-1-15","article-title":"Studies on ethacrynic acid in patients with refractory edema.","volume":"62","author":"Maher","year":"1965","journal-title":"Ann Intern Med"},{"key":"R23-15-20210202","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1001\/jama.1965.03090260008002","article-title":"Clinical experience with intravenous administration of ethacrynic acid.","volume":"194","author":"Irons","year":"1965","journal-title":"JAMA"},{"key":"R24-15-20210202","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/cpt196564474","article-title":"Metabolic effects and site of action of ethacrynic acid.","volume":"6","author":"Ledingham","year":"1965","journal-title":"Clin Pharmacol Ther"},{"key":"R25-15-20210202","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0002-9343(71)90216-6","article-title":"Hemodynamic effect of ethacrynic acid in patients with refractory acute left ventricular failure.","volume":"50","author":"Scheinman","year":"1971","journal-title":"Am J Med"},{"key":"R26-15-20210202","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0022-3565(25)27516-4","article-title":"Effects of several saluretic-diuretic agents on renal hemodynamics.","volume":"154","author":"Hook","year":"1966","journal-title":"J Pharmacol Exp Ther"},{"key":"R27-15-20210202","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0002-8703(66)90178-5","article-title":"Cardiorenal hemodynamic effects of ethacrynic acid.","volume":"71","author":"Nash","year":"1966","journal-title":"Am Heart J"},{"key":"R28-15-20210202","first-page":"654","article-title":"Differences in the acute effects of furosemide and ethacrynic acid in man.","volume":"71","author":"Stein","year":"1968","journal-title":"J Lab Clin Med"},{"key":"R29-15-20210202","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/S0022-3565(25)22526-5","article-title":"Pharmakokinetics and bioavailability study of ethacrynic acid as a modulator of drug resistance in patients with cancer.","volume":"270","author":"Lacreta","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"R30-15-20210202","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S0022-3565(25)30017-0","article-title":"Metabolism and biliary excretion of ethacrynic acid.","volume":"191","author":"Klaassen","year":"1974","journal-title":"J Pharmacol Exp Ther"},{"key":"R31-15-20210202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-3565(25)26945-2","article-title":"Renotropic characteristics of ethacrynic acid: a phenoxyacetic saluretic-diuretic agent.","volume":"147","author":"Beyer","year":"1965","journal-title":"J Pharmacol Exp Ther"},{"key":"R32-15-20210202","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1517\/14728222.5.4.477","article-title":"Glutathione S-transferases as emerging therapeutic targets.","volume":"5","author":"Gate","year":"2001","journal-title":"Expert Opin Ther Targets"},{"key":"R33-15-20210202","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/bjc.1992.145","article-title":"A study of ethacrynic acid as a potential modifier of melphalan and cisplatin sensitivity in human lung cancer parental and drug-resistant cell lines.","volume":"65","author":"Rhodes","year":"1992","journal-title":"Br J Cancer"},{"key":"R34-15-20210202","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2141.1993.tb03187.x","article-title":"Reversing of chlorambucil resistance by ethacrynic acid in a B-CLL patient.","volume":"85","author":"Petrini","year":"1993","journal-title":"Br J Haematol"},{"key":"R35-15-20210202","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0360-3016(95)02040-3","article-title":"Ethacrynic acid: a novel radiation enhancer in human carcinoma cells.","volume":"34","author":"Khil","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R36-15-20210202","doi-asserted-by":"crossref","first-page":"4056","DOI":"10.1016\/j.bmc.2005.03.046","article-title":"Synthesis and structure-activity relationship of ethacrynic acid analogues on glutathione-s-transferase P1-1 activity inhibition.","volume":"13","author":"Zhao","year":"2005","journal-title":"Bioorg Med Chem"},{"key":"R37-15-20210202","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/0002-8703(73)90434-1","article-title":"Toxicity of ethacrynic acid and furosemide.","volume":"85","author":"Cooperman","year":"1973","journal-title":"Am Heart J"},{"key":"R38-15-20210202","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.heares.2006.07.015","article-title":"Cell death after co-administration of cisplatin and ethacrynic acid.","volume":"226","author":"Ding","year":"2007","journal-title":"Hear Res"},{"key":"R39-15-20210202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5955(02)00585-3","article-title":"Ethacrynic acid rapidly and selectively abolishes blood flow in vessels supplying the lateral wall of the cochlea.","volume":"173","author":"Ding","year":"2002","journal-title":"Hear Res"},{"key":"R40-15-20210202","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/BF00169028","article-title":"Comparative acute ototoxicity of loop diuretic compounds.","volume":"248","author":"Rybak","year":"1991","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"R41-15-20210202","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1001\/jama.1969.03160240024005","article-title":"Intravenously given ethacrynic acid and gastrointestinal bleeding. A finding resulting from comprehensive drug surveillance.","volume":"209","author":"Slone","year":"1969","journal-title":"JAMA"}],"container-title":["American Journal of Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00045391-200901000-00015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:28:47Z","timestamp":1786040927000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00045391-200901000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/mjt.0b013e318195e460","relation":{},"ISSN":["1075-2765"],"issn-type":[{"value":"1075-2765","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}